Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Could umbilical cord stem cells cure blood cancer?

Written by | 9 Jan 2022

Stem cells have promised to be the catalyst for major strides in medical research for decades. While progress in some fields has been slower than initially hoped, scientists… read more.

Sloan Kettering Institute scientists design CAR T cells to activate cancer pro-drugs at the disease site

Written by | 8 Jan 2022

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.

Cancer deaths rose to 10 million worldwide in 2019

Written by | 7 Jan 2022

Recent trends also highlight global disparities in cancer burden. Cancer deaths rose to 10 million and new cases jumped to over 23 million globally in 2019, according to… read more.

Radiation monotherapy shows efficacy for treating oligometastatic renal cell carcinoma

Written by | 27 Dec 2021

Radiation monotherapy is an effective noninvasive treatment for oligometastatic renal cell carcinoma (RCC), researchers reported on Oct. 28, 2021 in The Lancet Oncology. “These findings are exciting because… read more.

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease,… read more.

Research demonstrates that cells with cancer-associated mutations overtake human tissue with age

Written by | 23 Dec 2021

It’s worth noting, in light of recently published research, that a majority of people won’t be diagnosed with cancer in their lifetimes. According to the National Cancer Institute,… read more.

FDA approves Tecartus for B-cell precursor acute lymphoblastic leukemia – Kite

Written by | 21 Dec 2021

Kite announced the FDA has granted approval for Tecartus (brexucabtagene autoleucel) for the treatment of adult patients (18 years and older) with relapsed or refractory B-cell precursor acute… read more.

Opdivo + Yervoy demonstrates durable overall survival at three years compared to chemotherapy in first-line unresectable malignant pleural mesothelioma – BMS

Written by | 15 Dec 2021

– Bristol Myers Squibb announced three-year data from the CheckMate -743 trial that demonstrated a durable survival benefit with first-line treatment with Opdivo (nivolumab) plus Yervoy (ipilimumab) compared… read more.

New findings on bacteria that increase risk of pancreatic cancer

Written by | 12 Dec 2021

Bacteria from the digestive system seem to have the potential to cause damage to pancreatic cells, increasing the risk of malignant tumours. Now for the first time, live… read more.

Statin use affects prostate cancer screening results

Written by | 10 Dec 2021

Prostate cancer screening results differ in men taking cholesterol-lowering statin drugs compared with non-users, a study conducted at Tampere University in Finland finds. In statin users, screening did… read more.

Dexamethasone treatment increases survival in some cancers

Written by | 8 Dec 2021

Patients with certain types of cancer appear to have better survival rates if they are treated during surgery with the anti-nausea drug dexamethasone. The finding was reported on… read more.

Air pollution linked to rise of lung cancer

Written by | 6 Dec 2021

Findings also reveal decline in smoking led to decrease in another type of lung cancer. An international team of scientists, led by Nanyang Technological University, Singapore (NTU Singapore),… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.